Skip to content

MEDIDEVS

Active
Private limited companyfounded 20206 yrs activeSperwerlaan 6, 2280 Grobbendonk, BelgiumKBO/BCE: BE 0753.600.819
Summary

MEDIDEVS has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €105k and a net result of €32k. Equity is growing by ~39% per year across the filed fiscal years. Its solvency ranks better than 86% of 4352 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.7% (low).

Checked score

Score 2024
Axes · tick = 2023
Profitability100=
Solvency100▲+10
Growth78=
Track record100
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9k at 30 days acceptable
Liquidity ample (current ratio 6.43 against 2.61 in 2023; short-term debt: 13.2% and cash: 50.4% of total assets), and 15% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Three signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 6 years 0 10 y
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 74
Relative position
BE, all sectors
reference
Other professional, scientific and technical activities (NACE 74)
about 48% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-05-2025, 66 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
not confirmed
2024
66 d early
2023
33 d early
2022
on the day
2021
31 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity
€105k▲ 6.7%
2023 · €98k
2021: €24klowest in 4 years 2022: €59k▲ +141% vs 2021 2023: €98k▲ +67.5% vs 2022 2024: €105k▲ +6.7% vs 2023highest in 4 years
2021 → 2024
Total assets
€124k▼ 18.9%
2023 · €152k
2021: €53klowest in 4 years 2022: €94k▲ +76.5% vs 2021 2023: €152k▲ +62.6% vs 2022highest in 4 years 2024: €124k▼ -18.9% vs 2023
2021 → 2024
Net result
€32k▼ 66.2%
2023 · €94k
2021: €14klowest in 4 years 2022: €48k▲ +236% vs 2021 2023: €94k▲ +93.8% vs 2022highest in 4 years 2024: €32k▼ -66.2% vs 2023
2021 → 2024
Working capital
€88k▲ 10.7%
2023 · €80k
2021: €13klowest in 4 years 2022: €46k▲ +268% vs 2021 2023: €80k▲ +72.7% vs 2022 2024: €88k▲ +10.7% vs 2023highest in 4 years
2021 → 2024
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line2021202220232024Trend
Equity€24k-€59k▲ 141%€98k▲ 67.5%€105k▲ 6.7% 2021: €24klowest in 4 years 2022: €59k▲ +141% vs 2021 2023: €98k▲ +67.5% vs 2022 2024: €105k▲ +6.7% vs 2023highest in 4 years
Operating result€22k-€64k▲ 193%€125k▲ 94.6%€47k▼ 62.2% 2021: €22klowest in 4 years 2022: €64k▲ +193% vs 2021 2023: €125k▲ +94.6% vs 2022highest in 4 years 2024: €47k▼ -62.2% vs 2023
Net result€14k-€48k▲ 236%€94k▲ 93.8%€32k▼ 66.2% 2021: €14klowest in 4 years 2022: €48k▲ +236% vs 2021 2023: €94k▲ +93.8% vs 2022highest in 4 years 2024: €32k▼ -66.2% vs 2023
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2021: €22k€22kNet result 2021: €14k€14kOperating result 2022: €64k€64kNet result 2022: €48k€48kOperating result 2023: €125k€125kNet result 2023: €94k€94kOperating result 2024: €47k€47kNet result 2024: €32k€32k2021202220232024€0€50k€100k€150kOperating result 2022: €64k€64kNet result 2022: €48k€48kOperating result 2023: €125k€125kNet result 2023: €94k€94kOperating result 2024: €47k€47kNet result 2024: €32k€32k202220232024
The operating result falls in 2024; 2024 is 62% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €124k
Fixed assets €19k ▼ 17.1%
Current assets €105k ▼ 19.2%
Equity and liabilities €124k
Equity €105k ▲ 6.7%
Debt €19k ▼ 65.7%
Debt's share of the balance-sheet total falls from 35.4% to 15.0%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€52k▼
2023 · €129k
Cash flow
€36k▼
2023 · €97k
Current ratio
6.43▲
2023 · 2.61
Debt to equity
0.18▼
2023 · 0.55
ROE
30.1%▼
2023 · 95.2%
ROA
25.6%▼
2023 · 61.5%
Interest coverage
15.57▼
2023 · 79.11
Debt ≤ 1 year
€16k▼
2023 · €50k
Income taxes
€13k▼
2023 · €30k
Staff costs
€17k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 50 lines
Balance sheet Code20232024
Assets
Total assets20/58€152k€124k▼
Fixed assets21/28€23k€19k▼
Tangible fixed assets22/27€23k€19k▼
Plant, machinery and equipment23€436€238▼
Furniture and vehicles24€5k€4k▼
Other tangible fixed assets26€18k€15k▼
Current assets29/58€129k€105k▼
Amounts receivable within one year40/41€36k€41k▲
Trade receivables40€33k€23k▼
Other amounts receivable41€3k€18k▲
Cash at bank and in hand54/58€91k€62k▼
Deferred charges and accrued income490/1€2k€1k▼
Equity and liabilities
Total equity and liabilities10/49€152k€124k▼
Equity10/15€98k€105k▲
Contributions10/11€10k€10k=
Reserves13€88k€95k▲
Distributable reserves133€88k€95k▲
Amounts payable17/49€54k€19k▼
Amounts payable after more than one year17€2k-
Financial debts170/4€2k-
Amounts payable within one year42/48€50k€16k▼
Current portion of amounts payable after more than one year42€5k€2k▼
Financial debts43€4k€1k▼
Credit institutions430/8€4k€1k▼
Trade debts44€3k€2k▼
Suppliers440/4€3k€2k▼
Taxes, remuneration and social security45€36k€6k▼
Taxes450/3€34k€1k▼
Remuneration and social security454/9€2k€4k▲
Other amounts payable47/48€2k€6k▲
Accrued charges and deferred income492/3€2k€2k▼
Income statement Code20232024
Remuneration, social security and pensions62-€17k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€4k▲
Other operating charges640/8€2k€5k▲
Gross operating margin9900€131k€74k▼
Operating profit (loss)9901€125k€47k▼
Financial income75/76B€275€70▼
Recurring financial income75€275€70▼
Financial charges65/66B€2k€3k▲
Recurring financial charges65€2k€3k▲
Profit (loss) for the period before taxes9903€124k€44k▼
Income taxes67/77€30k€13k▼
Profit (loss) for the period9904€94k€32k▼
Profit (loss) for the period to be appropriated9905€94k€32k▼
Appropriation of the result
Profit (loss) to be appropriated9906€94k€32k▼
Transfer from equity791/2€39k€25k▼
Transfer to equity691/2€79k€32k▼
To other reserves6921€79k€32k▼
Profit to be distributed694/7€54k€25k▼
Return on contributions (dividend)694€54k€25k▼

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line2021202220232024Change
Remuneration, social security and pensions62---€17k-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€3k€3k€4k▲ 32.2%
Other operating charges640/8€1k€2k€2k€5k▲ 162%
Gross operating margin9900€26k€69k€131k€74k▼ 43.6%
Operating profit (loss)9901€22k€64k€125k€47k▼ 62.2%
Financial income75/76B-€2k€275€70▼ 74.6%
Recurring financial income75-€2k€275€70▼ 74.6%
Financial charges65/66B€918€3k€2k€3k▲ 104%
Recurring financial charges65€918€3k€2k€3k▲ 104%
Profit (loss) for the period before taxes9903€21k€63k€124k€44k▼ 64.4%
Income taxes67/77€7k€15k€30k€13k▼ 58.7%
Profit (loss) for the period9904€14k€48k€94k€32k▼ 66.2%
Profit (loss) for the period to be appropriated9905€14k€48k€94k€32k▼ 66.2%
Line2021202220232024Change
Assets
Total assets20/58€53k€94k€152k€124k▼ 18.9%
Fixed assets21/28€24k€22k€23k€19k▼ 17.1%
Tangible fixed assets22/27€24k€22k€23k€19k▼ 17.1%
Plant, machinery and equipment23€832€634€436€238▼ 45.5%
Furniture and vehicles24€1k€1k€5k€4k▼ 27.6%
Other tangible fixed assets26€22k€20k€18k€15k▼ 13.6%
Current assets29/58€29k€72k€129k€105k▼ 19.2%
Amounts receivable within one year40/41€25k€45k€36k€41k▲ 13.9%
Trade receivables40€11k€20k€33k€23k▼ 31.2%
Other amounts receivable41€14k€25k€3k€18k▲ 495%
Cash at bank and in hand54/58€2k€25k€91k€62k▼ 31.8%
Deferred charges and accrued income490/1€1k€2k€2k€1k▼ 38.6%
Equity and liabilities
Total equity and liabilities10/49€53k€94k€152k€124k▼ 18.9%
Equity10/15€24k€59k€98k€105k▲ 6.7%
Contributions10/11€10k€10k€10k€10k=
Reserves13€14k€49k€88k€95k▲ 7.5%
Distributable reserves133€14k€49k€88k€95k▲ 7.5%
Amounts payable17/49€29k€35k€54k€19k▼ 65.7%
Amounts payable after more than one year17€11k€7k€2k--
Financial debts170/4€11k€7k€2k--
Amounts payable within one year42/48€16k€26k€50k€16k▼ 67.2%
Current portion of amounts payable after more than one year42-€5k€5k€2k▼ 57.4%
Financial debts43€759€559€4k€1k▼ 75.8%
Credit institutions430/8€759€559€4k€1k▼ 75.8%
Trade debts44€9k€1k€3k€2k▼ 27.7%
Suppliers440/4€9k€1k€3k€2k▼ 27.7%
Taxes, remuneration and social security45€7k€19k€36k€6k▼ 84.3%
Taxes450/3€7k€19k€34k€1k▼ 96.1%
Remuneration and social security454/9--€2k€4k▲ 98.9%
Other amounts payable47/48--€2k€6k▲ 260%
Accrued charges and deferred income492/3€2k€2k€2k€2k▼ 4.7%
Line2021202220232024Change
Profit (loss) for the period9904€14k€48k€94k€32k▼ 66.2%
+ Depreciation and write-downs630€2k€3k€3k€4k▲ 32.2%
Operating cash flow (approximation)€17k€52k€97k€36k▼ 62.9%
Investment in fixed assets (approximation)-€-660€-4k€-330▲ 92.3%
Change in cash-€23k€66k€-29k▼ 144%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

2025
26-05
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Liquidity doublescurrent ratio 6.43
Current ratio from 2.61 to 6.43; short-term debt falls from €50k to €16k.
31-12
Financial Equity above €100kEq €105k ▲6.7%
4 profitable years in a row build equity to €105k.
28-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Highest result since 2021net €94k ▲93.8%
Operating result €125k, net result €94k, both a record.
31-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
Location & real-estate footprint
Registered office, Grobbendonk · 1 establishment unit since 2020
seat establishment The establishment unit on the map
Ground area
1,138 m²
Building footprint
140 m²
Volume, LiDAR
725 m³
Parcel 13010C0039/00T002, Flanders · tallest building 7.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
MEDIDEVS
Sperwerlaan 6, 2280 GrobbendonkComputing infrastructure, data processing, hosting and other information service activities
since 20202.309.108.358
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
13010C0039/00T002 Flanders 1,138 m² 1 · 140 m² 7.8 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 4,564 companies in sector 74999 we hold annual accounts for 1,936. 1,547 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded02-09-2020
Fiscal year end31-12
Activities, NACEBEL 2025
74999Other professional, scientific and technical activities
63920Other information service activities
Contact
E-mail dirk.joostens@medidevs.be
Phone 0468221332
Phone 0467221332Grobbendonk

Scores and ratios are computed by Checked and are not a credit decision.